Articles related to VACCINES/IMMUNIZATION

The FDA’s approval of new COVID-19 vaccines targeting the KP.2 strain comes amidst concerns about waning immunity and evolving virus variants.

The CDC reports “very high” COVID-19 levels in 32 states, with two new Omicron variants accounting for more than half of all US cases.

The 2022 ACIP recommendations introduce new pneumococcal conjugate vaccines and simplified dosing schedules, aiming to enhance prevention of invasive pneumococcal disease while improving guideline implementation in clinical practice.

Immunocompromised individuals are at a 6 to 11 times higher risk of developing herpes zoster compared to the general population, with hematopoietic stem cell transplant recipients facing the highest risk.

C-section deliveries may have long-term consequences on infant immunity, potentially affecting vaccine efficacy and increasing the risk of certain health conditions.

Recent research indicates that myocarditis and pericarditis occur solely in vaccinated children and adolescents, not in those infected with COVID-19. Despite higher risks of heart inflammation, vaccinated adolescents showed reduced rates of COVID-19 infection and severe outcomes.